title: Performing trials in children with rheumatic diseases: comment on the editorial by Lehman.
authors.forename: Nicolino
authors.initials: N
authors.lastname: Ruperto
authors.forename: Alberto
authors.initials: A
authors.lastname: Martini
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Lovell
authors.forename: Edward H
authors.initials: EH
authors.lastname: Giannini
mesh_terms: D000367:Age Factors; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005062:European Union; D006801:Humans; D015203:Reproducibility of Results; D014481:United States
chemical_list: D018501:Antirheumatic Agents